Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 6, 1999, Pages 812-818

  Qadri, Firdausi ^a,d   Ahmed, Firoz ^a   Karim, M Manjurul ^a   Wenneras, Christine ^b   Begum, Yasmin Ara ^a   Salam, Mohammad Abdus ^a   Albert, M John ^a   McGhee, Jerry R ^c  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d ICDDRB Laboratory Sciences Division   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHOLERA TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN SUBCLASS; TOXIN ANTIBODY;

ADULT; ANTIBODY PRODUCING CELL; ANTIBODY SPECIFICITY; ARTICLE; CHOLERA; CLINICAL ARTICLE; CONTROLLED STUDY; FECES LEVEL; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; MALE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIBRIO CHOLERAE;

EID: 0032706801     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.6.812-818.1999     Document Type: Article

References (41)

1. Ahren, C., C. Wenneras, J. Holmgren, and A.-M. Svennerholm. 1993. Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine. Vaccine 11:929-939.
2. Albert, M. J., A. K. Siddique, M. S. Islam, A. S. G. Faruque, M. Ansaruzzaman, S. M. Faruque, and R. B. Sack. 1993. A large outbreak of clinical cholera due to V. cholerae non-O1 in Bangladesh. Lancet 341:704. (Letter.)
3. Barington, T., L. Juul, A. Gyhrs, and C. Heilmann. 1994. Heavy-chain isotype patterns of human antibody-secreting cells induced by Haemophihis influenzae type b conjugate vaccines in relation to age and preimmunity. Infect. Immun. 62:3066-3074.
4. Benenson, A. S., M. R. Islam, and W. B. Greenough III. 1964. Rapid identification of Vibrio cholerae by dark field microscopy. Bull. W. H. O. 30:827-831.
5. Bjerke, K., and P. Brandtzaeg. 1990. Terminally differentiated human intestinal B cells. IgA and IgG subdass-producing immunocytes in the distal ileum, including Fever's patches, compared with lymph nodes and palatine tonsils. Scand. J. Immunol. 32:61-67.
6. Bradwell, A. R. 1993. IgG subclasses in diseases, 2nd ed., p. 4-5. Kidderminster Worcester, England.
7. Brandtzaeg, P. 1994. Distribution and characteristics of mucosal immunoglobulin producing cells, p. 251-262. In P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. R. McGhee, and J. Bienenstock (ed.), Handbook of mucosal immunology. Academic Press Inc. New York, N. Y.
8. Clements, M. L., M. M. Levine, C. R. Young, R. E. Black, Y. L. Lim, R. M. Robins-Browne, and J. P. Craig. 1982. Magnitude, kinetics and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. J. Infect. Dis. 143:818-820.
9. Czerkinsky, C., Z. Moldoveanu, J. Mestecky, L. A. Nilsson, and O. Ouchterlony. 1988. A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells. J. Immunol. Methods 115:31-37.
10. Czerkinsky, C., A.-M. Svennerholm, and J. Holmgren. 1993. Induction and assessment of immunity at enteromucosal surfaces in humans: implications for vaccine development. Clin. Infect. Dis. 16:S106-S116.
11. Elson, C. O., W. Walding, S. Woogen, and M. Gaspari. 1988. Some new perspectives on IgA immunization and oral tolerance derived from the unusual properties of cholera toxin as a mucosal immunogen, p. 392-400. In W. Strober, M. E. Lamm, J. R. McGhee, and S. P. James (ed.), Mucosal immunity and infections at mucosal surfaces. Oxford University Press, New York, N.Y.
12. Feinstein, D., and E. C. Franklin. 1966. Two antigenically distinguishable subclasses of human A myeloma proteins differing in their heavy chains. Nature 212:1496-1498.
13. Freijd, A., L. Hammarstrom, M. A. A. Persson, and C. I. E. Smith. 1984. Specific antibody levels in otitiis prone children. I. An analysis of plasma anti-pneumococcal antibody activity of the IgG class and subclasses. Clin. Exp. Immunol. 56:233-238.
14. Hisatunse, K., R. S. Kondo, Y. Isshiki, T. Iguchi, U. Kawamata, and T. Shimada. 1993. O-antigenic lipopolysaccharide of Vibrio cholerae O139 Bengal, a new epidemic strain for recent cholera in the Indian subcontinent. Biochem. Biophys. Res. Commun. 196:1309-1315.
15. Holmgren, J., and A.-M. Svennerholm. 1983. Cholera and the immune response. Prog. Allergy 33:106-119.
16. Jertborn, M., A.-M. Svennerholm, and J. Holmgren. 1996. Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit O1/O139 whole cell cholera vaccine. Vaccine 14:1459-1465.
17. Jertborn, M., A.-M. Svennerholm, and J. Holmgren. 1988. IgG and IgA subclass distribution of antitoxin antibody responses after oral cholera vaccination or cholera disease. Int. Arch. Allergy Appl. Immunol. 85:358-363.
18. Jertborn, M., A.-M. Svennerholm, and J. Holmgren. 1986. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J. Clin. Microbiol. 24:203-209.
19. Kett, K., P. Brandtzaeg, J. Radl, and J. F. Haaijman. 1986. Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J. Immunol. 136:3631-3635.
20. Levine, M. M., R. E. Black, M. L. Clements, L. Cisneros, D. R. Nalin, and C. R. Young. 1981. Duration of infection derived immunity to cholera. J. Infect. Dis. 143:818-820.
21. Losonsky, G. A., J. Yunyongying, V. Lim, M. Reymann, Y. L. Lim, S. S. Wasserman, and M. M. Levine. 1996. Factors influencing secondary vibrio-cidal immune responses: relevance for understanding immunity to cholera. Infect. Immun. 64:10-15.
22. Marinaro, M., H. F. Staats, T. Hiroi, R. J. Jackson, M. Costo, P. N. Boyaka, N. Okahashi, M. Yamamoto, H. Kiyono, H. Bluethmann, K. Fujihashi, and J. R. McGhee. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and 1L-4. J. Immunol. 155:4621-4629.
23. McDermott, M. R., and J. Bienestock. 1979. Evidence for a common mucosal immune system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 122:1892-1898.
24. Monsur, K. A. 1961. A highly selective gelatin-taurocholate tellurite medium for the isolation of Vibrio cholerae. Trans. R. Soc. Trop. Med. Hyg. 5:440-442.
25. Ogawa, T., A., Tarkowski, M. L. McGhee, Z. Moldoveanu, J. Mestecky, H. Z. Hirsch, W. J. Koopman, S. Hamada, J. R. McGhee, and H. Kiyono. 1989. Analysis of human IgG and IgA subclass antibody-secreting cells from localized chronic inflammatory tissue. J. Immunol. 142:1150-1158.
26. Qadri, F., G. Jonson, Y. A. Begum, C. Wennerås, M. J. Albert, M. A. Salam, and A.-M. Svennerholm. 1997. Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O139. Clin. Diagn. Lab. Immunol. 4:429-434.
27. Qadri, F., G. Mohi, J. Hossain, T. Azim, A. M. Khan, M. A. Salam, R. B. Sack, M. J. Albert, and A.-M. Svennerholm. 1995. Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae 0139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin. Diagn. Lab. Immunol. 2:685-688.
28. Qadri, F., C. Wennerås, M. J. Albert, J. Hossain, K. Mannoor, Y. A. Begum, G. Mohi, M. A. Salam, R. B. Sack, and A.-M. Svennerholm. 1997. Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect. Immun. 65:3571-3576.
29. Russel, M. W., M. Kilian, and M. E. Lamm. 1999. Biological activities of IgA, p. 225-240. In P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strobcr, J. Bienenstock, and J. R. McGhee (ed.), Handbook of mucosal immunology, 2nd ed. Academic Press Inc., New York, N.Y.
30. Sanchez, J., and J. Holmgren. 1989. Recombinant system for over-expression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc. Natl. Acad. Sci. USA 86:481-485.
31. Schreiber, J. R., V. Barrus, K. L. Cates, and G. R. Siber. 1986. Functional characterization of human IgG, IgM and IgA antibody directed to the capsule of Haemophilus influenzae type b. J. Infect. Dis. 153:8-16.
32. Shakib, F. 1986. The IgG4 subclass. Monogr. Allergy 19:223-226.
33. Svennerholm, A.-M., and J. Holmgren. 1976. Synergistic protective effect in rabbits of immunization with Vibrio cholerae. Infect. Immun. 13:735-740.
34. Svennerholm, A.-M., J. Holmgren, R. Black, M. Levine, and M. Merson. 1983. Serologic differentiation between antitoxic response to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. J. Infect. Dis. 147:514-521.
35. Svennerholm, A.-M., M. Jertborn, L. Gothefors, M. M. Karim, D. A. Sack, and J. Holmgren. 1984. Mucosal antibodies and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J. Infect. Dis. 149:884-893.
36. Tacket, C. O. G. A. Losonsky, J. P. Nataro, S. J. Cryz, R. Edelman, J. B. Kaper, and M. M. Levine. 1992. Onset and duration of protective immunity in challenged volunteers after vaccination with live and cholera vaccine CVD 103-HgR. J. Infect. Dis. 166:837-841.
37. Waldor, M. K., R. Colwell, and J. J. Mekalanos. 1994. The Vibrio cholerae O139 serogroup antigen includes capsular and lipopolysaccharide virulence determinants. Proc. Natl. Acad. Sci. USA 91:11388-11392.
38. Wennerås, C., A.-M. Svennerholm, A.-C. Ahren, and C. Czerkinsky. 1992. Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine. Infect. Immun. 60:2605-2611.
39. World Health Organization. 1987. Programme for control of diarrhoeal diseases (CDD/83.3 Rev 1), p. 9-20. In Manual for laboratory investigations of acute enteric infections. World Health Organization. Geneva, Switzerland.
40. World Health Organization. 1990. Manual for the treatment of diarrhoea: for use by physicians and other senior health workers (WHO/CDD SER/ 80-2, Rev. 2). World Health Organization, Geneva, Switzerland.
41. World Health Organization. 1993. Epidemic diarrhoea due to Vibrio cholerae non-O1. Weekly Epidemiol. Rec. 68:141-142.